Sulforaphane: The Definitive Guide

What is sulforaphane?

Sulforaphane is an isothiocyanate formed when glucoraphanin from broccoli and other cruciferous plants meets the enzyme myrosinase. It is a phytochemical, not an essential nutrient, and has no RDA, adequate intake, tolerable upper intake level or deficiency syndrome.

That conversion step is central. Fresh sprouts, cooked broccoli, broccoli-seed extract and a glucoraphanin-plus-myrosinase capsule can create very different exposure even when their front labels sound similar. Human studies also use different units, formulations and endpoints, so their schedules are not interchangeable. [1]–[4]

Typical Sulforaphane Protocols

The Atwell comparison shows why a nominal sulforaphane-equivalent amount is not the same as measured exposure. The Nouchi study administered a precursor, while Dwibedi administered an extract designed to deliver sulforaphane. Preserve the exact label unit rather than converting between them.

Declared compound

Record glucoraphanin, sulforaphane equivalents or food weight exactly as stated.

Myrosinase

Record whether active myrosinase is present, absent or unreported; it changes conversion.

Endpoint

Choose exposure, cognition, fasting glucose, histology or a tissue biomarker before interpreting change.

What is sulforaphane commonly used for?

Cognition and mood

In 144 healthy older adults, 30 mg glucoraphanin as three capsules taken together daily for 12 weeks improved processing speed and reduced negative mood relative to placebo. Other oxidative-stress, inflammatory and neural-plasticity biomarkers were null. Multiple outcomes, healthy volunteers and company-linked product context make independent replication important. [5]

Glucose and metabolic health

The 2025 prediabetes trial missed its prespecified primary target of a 0.3 mmol/L fasting-glucose reduction versus placebo. The overall estimate was −0.2 mmol/L, while a larger “responder” effect and microbiome pattern came from exploratory subgroup analyses. This is a research lead, not a microbiome test for choosing treatment. [8]

A small fatty-liver study reported decreases in ALT, γ-GTP and urinary 8-OHdG within the active group over two months. The accessible abstract does not provide a clear between-group effect estimate for each outcome, so within-group change should not be treated as proof of treatment efficacy. [7]

Cancer-risk biomarkers

In former smokers, 95 μmol/day for 12 months changed bronchial Ki-67 but not bronchial histopathology, caspase-3 or TUNEL. In men scheduled for prostate biopsy, 200 μmol/day increased metabolites and changed selected gene expression, while HDAC activity and several prostate-tissue biomarkers were null. These are biomarker studies, not evidence that supplements prevent cancer. [6], [9]

How do forms and labels differ?

Fresh sprouts contain precursor and plant myrosinase. Cooking can inactivate myrosinase. Some extracts state glucoraphanin only; others add active myrosinase or report a nominal sulforaphane yield. A proprietary blend that omits both quantities cannot be matched confidently to a trial.

In eight men, raw broccoli produced estimated bioavailability of 37% versus 3.4% cooked and reached peak plasma levels sooner. In 12 adults, adding 1 g brown mustard powder to 200 g cooked broccoli increased urinary SF-NAC more than fourfold. Both studies demonstrate exposure, not a health outcome. [2], [3]

How should sulforaphane products be stored?

Follow the finished product label for temperature, moisture and expiry. Keep capsules sealed and dry. Fresh sprouts are perishable and carry ordinary raw-sprout food-safety concerns; follow public-health handling advice and avoid home sprouting when a clinician advises against raw sprouts because of infection risk.

What does the human evidence show?

The evidence establishes that formulation changes exposure and that sulforaphane can engage biological pathways in humans. Clinical benefits remain condition-specific, small and uneven across endpoints. [1]–[10]

What are the risks and interactions?

Trials generally report tolerability, but GI symptoms occur and sample sizes are too small for uncommon harms. Record nausea, abdominal discomfort, bowel change, headache, rash, sleep change or another new symptom. Raw sprouts can carry foodborne pathogens.

Direct drug-interaction evidence is limited. Pregnancy, breastfeeding, childhood use, thyroid disease with low iodine intake, liver or kidney disease, cancer treatment and planned surgery warrant clinician review. A pathway hypothesis should not be used to alter chemotherapy or another prescription.

What is the legal and regulatory status?

In the United States, broccoli-derived products sold as supplements fall under dietary-supplement requirements; FDA does not approve them to treat prediabetes, fatty liver, cognitive decline or cancer. In Canada, verify the specific natural health product’s NPN or DIN-HM. Authorization of one finished product does not establish equivalent conversion or efficacy for another.

What happens when you stop?

Sulforaphane has no established withdrawal syndrome or evidence-based taper. Metabolite exposure falls after intake stops. Any perceived change may return toward baseline, but persistent cognitive, glucose, liver or GI concerns need appropriate clinical assessment.

What should you monitor?

Record product, glucoraphanin amount, stated sulforaphane yield, myrosinase source, amount at each administration, daily total, timing, preparation method and co-ingredients. Choose one outcome in advance. Glucose or liver monitoring should follow a clinician’s plan; a symptom log cannot diagnose or replace laboratory care.

What does community experience add?

Public reports may surface sprouting effort, odour, GI tolerance, cost and confusion about label units. They cannot verify conversion, Nrf2 activity, glucose benefit or cancer prevention. No systematic current community sample was assembled, so this guide reports no consensus protocol, brand or responder rate.

How does sulforaphane compare with related options?

Common questions

Is sulforaphane the same as glucoraphanin?

No. Glucoraphanin is the precursor; myrosinase converts it into sulforaphane.

Does cooking destroy sulforaphane?

Cooking can inactivate plant myrosinase and lower formation. In a small crossover, raw broccoli produced much higher exposure than cooked broccoli. [2]

Does mustard improve absorption?

One 12-person crossover found that 1 g brown mustard powder added to cooked broccoli increased urinary sulforaphane metabolite more than fourfold. This was an exposure result. [3]

Does sulforaphane lower blood glucose?

The 2025 prediabetes trial missed its prespecified target. A small overall effect and exploratory responder subgroup need confirmation. [8]

Does it prevent cancer?

No trial shows that taking sulforaphane prevents cancer. Human studies have measured surrogate biomarkers with mixed results. [6], [9]

Is it a detox supplement?

Sulforaphane can change Nrf2-regulated enzymes, but that does not prove broad toxin clearance or a clinical detoxification outcome.

Is there one best dose?

No. Trials use food weight, glucoraphanin or sulforaphane equivalents with different conversion systems. There is no universal dose.

Glossary

Plain explanations of sulforaphane research terms.

Glucoraphanin

A glucosinolate precursor that can be converted into sulforaphane.

Myrosinase

An enzyme from plants or microbes that helps convert glucoraphanin into sulforaphane.

Nrf2

A transcription factor regulating cellular stress-response genes; activation is not itself a clinical benefit.

SF-NAC

A urinary sulforaphane metabolite used to estimate exposure.

Ki-67

A cell-proliferation marker; a change does not prove fewer cancers.

Surrogate endpoint

A marker used in place of a direct patient outcome, whose clinical meaning may remain uncertain.

How this guide was researched

Ten PubMed identities and correction records were checked through NCBI EFetch. Full methods were used where accessible. Formulation, amount, administration count, exposure endpoint and clinical endpoint were extracted separately; null primary and tissue outcomes remain visible.

Explore the sources

Related guides

• DIM
• Indole-3-carbinol
• NAC
• Antioxidants

Editorial note

This guide keeps precursor, enzyme, measured exposure, pathway markers and clinical outcomes separate so better conversion is not presented as guaranteed benefit.